185 related articles for article (PubMed ID: 37024334)
1. Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons.
Welling DB
Otolaryngol Clin North Am; 2023 Jun; 56(3):543-556. PubMed ID: 37024334
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
3. Management of multiple tumors in neurofibromatosis type 2 patients.
Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatoses. Part 2: NF2 and schwannomatosis.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(3):E81-6. PubMed ID: 19898272
[TBL] [Abstract][Full Text] [Related]
5. A Diagnostic Dilemma: Multiple Primary Intracranial Tumors Without Vestibular Schwannomas.
Faucett EA; Larsen BT; Khan R; Chiu AG; Chang EH
Ann Otol Rhinol Laryngol; 2016 Nov; 125(11):938-942. PubMed ID: 27553596
[TBL] [Abstract][Full Text] [Related]
6. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation.
Mehta GU; Feldman MJ; Wang H; Ding D; Chittiboina P
J Neurosurg; 2016 Dec; 125(6):1469-1471. PubMed ID: 26848914
[TBL] [Abstract][Full Text] [Related]
7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
Van Gompel JJ; Agazzi S; Carlson ML; Adewumi DA; Hadjipanayis CG; Uhm JH; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E52-E54. PubMed ID: 29309638
[TBL] [Abstract][Full Text] [Related]
8. Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.
Rodriguez FJ; Scheithauer BW; George D; Midha R; MacCollin M; Stemmer-Rachamimov AO
Acta Neuropathol; 2011 May; 121(5):663-8. PubMed ID: 21191601
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
[TBL] [Abstract][Full Text] [Related]
11. [Segmental schwannomatosis in upper-extremity: 5 cases report and literature review].
Wang ZX; Chen SL; Yi CJ; Li C; Rong YB; Tian GL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):698-703. PubMed ID: 24136261
[TBL] [Abstract][Full Text] [Related]
12. [Treatment research progress on the treatment of neurofibromatosis type 2-associated vestibular schwannoma].
Zhao Y; Yang Q; Jiang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):955-8. PubMed ID: 26596021
[TBL] [Abstract][Full Text] [Related]
13. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
14. Natural history of vestibular schwannomas and hearing loss in NF2 patients.
Peyre M; Bernardeschi D; Sterkers O; Kalamarides M
Neurochirurgie; 2018 Nov; 64(5):342-347. PubMed ID: 26183546
[TBL] [Abstract][Full Text] [Related]
15. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
17. Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series.
Douwes JPJ; Koetsier KS; van Dam VS; Plotkin SR; Barker FG; Welling DB; Jansen JC; Hensen EF; Shih HA
Curr Oncol; 2023 Mar; 30(3):3473-3483. PubMed ID: 36975476
[TBL] [Abstract][Full Text] [Related]
18. Management of Vestibular Schwannoma (Including NF2): Facial Nerve Considerations.
Kaul V; Cosetti MK
Otolaryngol Clin North Am; 2018 Dec; 51(6):1193-1212. PubMed ID: 30390772
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
Rosahl S; Bohr C; Lell M; Hamm K; Iro H
Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
[TBL] [Abstract][Full Text] [Related]
20. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Cumpston EC; Rhodes SD; Yates CW
Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
